Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
about
Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in miceCoagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis.Mortality factor 4 like 1 protein mediates epithelial cell death in a mouse model of pneumoniaKeap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feedingRole of hemostatic factors in hepatic injury and disease: animal models de-liver.Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?Platelets in inflammation and immunity.Thrombin promotes diet-induced obesity through fibrin-driven inflammation.Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.Cytoplasmic domain of tissue factor promotes liver fibrosis in miceFrom the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.
P2860
Q33424466-D084906E-CE8D-4FDE-811F-3B05A5208978Q34360710-085A118A-E390-4195-8E78-E86C1FC3B870Q35806023-87C42D29-CC5A-43D9-BF24-A36F28B32DAAQ36307276-701B13EA-41C6-492C-ADFE-C341A3C57D1DQ36593428-557B17C9-63BB-4B74-8880-A14DA91F3B47Q37231144-F354796F-59AE-458F-8DCC-C5F1D9DB1D41Q37387653-C665AAD9-ED3E-4615-882D-CA78A1802CDAQ37681886-4AAA7323-B829-4EA3-86B7-382E27207744Q38249957-FFC05CAD-D838-419B-9E34-265113B297D4Q38665177-C0C87854-5C08-47B1-BDC3-3935E0D93EFEQ40127983-4E4AE5A2-6E88-487A-BD85-22B3EFE9317DQ41505574-5F90A4AA-ABD4-42C0-9471-E0F3EE78A0A7Q44508881-C224BAEE-9631-47CE-A099-53F2A08D3F40
P2860
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Therapeutic administration of ...... tablished fatty liver disease.
@ast
Therapeutic administration of ...... tablished fatty liver disease.
@en
type
label
Therapeutic administration of ...... tablished fatty liver disease.
@ast
Therapeutic administration of ...... tablished fatty liver disease.
@en
prefLabel
Therapeutic administration of ...... tablished fatty liver disease.
@ast
Therapeutic administration of ...... tablished fatty liver disease.
@en
P2093
P2860
P1476
Therapeutic administration of ...... tablished fatty liver disease.
@en
P2093
Bradley P Sullivan
Bryan L Copple
James P Luyendyk
Karen M Kassel
P2860
P304
P356
10.1016/J.AJPATH.2012.06.011
P407
P577
2012-07-26T00:00:00Z